AVNS Stock Analysis: Buy, Sell, or Hold?
AVNS - Avanos Medical, Inc.
$24.99
0.01 (0.04%)
▲
5d:
+0.08%
30d:
+0.16%
90d:
+1.13%
BUY
MODERATE Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Get Alerted When AVNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 8.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 8.4% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.22
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$23.73
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVNS is currently trading at $24.99, which is considered slightly high relative to its 30-day fair value range of $24.86 to $25.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.0) compared to its historical average (15.7). At these levels, the market is pricing in 8.4% annual earnings growth.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AVNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $14.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AVNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $14.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$24.86 -
$25.00
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 44.0% above Wall St target ($14.00)
- BULLISH: Expecting earnings turnaround to 8.4% growth with 8.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$24.86 -
$25.00
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$24.93
Resistance Level
$25.00
Current Trend
Strong Uptrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.99
Wall Street Target
$14.00
(-44.0%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
-21.7%
Profit Margin
-10.4%
Valuation Premium vs History
+8.4% premium
PE vs Historical
20.0 vs 15.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.4%
(market-implied from PE analysis)
1-Year Target
$27.09
(+8%)
2-Year Target
$29.36
(+18%)
3-Year Target
$31.83
(+27%)
3-Yr Target (if PE normalizes)
(PE: 20→16)
PE COMPRESSION
$25.00
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 25.0%)
$50.81
(+103%)
Base:
(SPY PE: 20.0, Growth: 25.0%)
$48.81
(+95%)
Bear:
(PE: 15.7, Growth: 25.0%)
$38.33
(+53%)
Share & Embed Analysis
Last updated: August 03, 2026 2:57 AM ET
Data refreshes hourly during market hours. Next update: 3:57 AM
Data refreshes hourly during market hours. Next update: 3:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
